These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7529793)

  • 21. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex.
    Vasmatzis G; Cornette J; Sezerman U; DeLisi C
    J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide-binding motif prediction by using phage display library for SasaUBA*0301, a resistance haplotype of MHC class I molecule from Atlantic Salmon (Salmo salar).
    Zhao H; Hermsen T; Stet RJ; Skjødt K; Savelkoul HF
    Mol Immunol; 2008 Mar; 45(6):1658-64. PubMed ID: 18206244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-dimensional nuclear magnetic resonance analysis of a labeled peptide bound to a class II major histocompatibility complex molecule.
    Driscoll PC; Altman JD; Boniface JJ; Sakaguchi K; Reay PA; Omichinski JG; Appella E; Davis MM
    J Mol Biol; 1993 Jul; 232(2):342-50. PubMed ID: 8393933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of class I MHC folding intermediates and their disparate interactions with peptide and beta 2-microglobulin.
    Smith JD; Solheim JC; Carreno BM; Hansen TH
    Mol Immunol; 1995 May; 32(7):531-40. PubMed ID: 7783756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of peptide binding to purified antibody-bound H-2Db and H-2Db beta 2m complexes.
    Burshtyn DN; Barber BH
    J Immunol; 1993 Sep; 151(6):3082-93. PubMed ID: 7690793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC class I/peptide interactions: binding specificity and kinetics.
    Margulies DH; Corr M; Boyd LF; Khilko SN
    J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.
    van der Burg SH; Visseren MJ; Brandt RM; Kast WM; Melief CJ
    J Immunol; 1996 May; 156(9):3308-14. PubMed ID: 8617954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of class I major histocompatibility heavy and light chains induced by viral peptides.
    Townsend A; Ohlén C; Bastin J; Ljunggren HG; Foster L; Kärre K
    Nature; 1989 Aug; 340(6233):443-8. PubMed ID: 2666863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural analysis of MHC class I molecules with bound peptide antigens.
    Wilson IA; Fremont DH
    Semin Immunol; 1993 Apr; 5(2):75-80. PubMed ID: 8504218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino acid changes in the peptide binding site have structural consequences at the surface of class I glycoproteins.
    Pease LR; Horton RM; Pullen JK; Hunt HD; Yun TJ; Rohren EM; Prescott JL; Jobe SM; Allen KS
    J Immunol; 1993 Apr; 150(8 Pt 1):3375-81. PubMed ID: 7682238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
    Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
    J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide interactions with class I and II MHC encoded molecules.
    Pecht I
    Isr J Med Sci; 1994 Mar; 30(3):28-31. PubMed ID: 7514162
    [No Abstract]   [Full Text] [Related]  

  • 36. HLA-E and the origin of immunogenic self HLA epitopes.
    Lo Monaco E; Tremante E; Cifaldi L; Fruci D; Giacomini P
    Mol Immunol; 2010 May; 47(9):1661-2; author reply 1163-4. PubMed ID: 20096934
    [No Abstract]   [Full Text] [Related]  

  • 37. Alloreactive cytotoxic T lymphocytes recognize epitopes determined by both the alpha helices and beta sheets of the class I peptide binding site.
    Hunt HD; Munitz TI; Pease LR
    J Exp Med; 1992 Mar; 175(3):821-9. PubMed ID: 1371305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC class I heavy chain-dependent expression of discontinuous antigenic epitopes on beta 2-microglobulinb is inducible with peptide-ligand.
    Tatake RJ; Trymbulak WP; Zeff RA
    Transplantation; 1995 Jan; 59(1):124-30. PubMed ID: 7530867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model for the in vivo assembly of nascent Ld class I molecules and for the expression of unfolded Ld molecules at the cell surface.
    Smith JD; Myers NB; Gorka J; Hansen TH
    J Exp Med; 1993 Dec; 178(6):2035-46. PubMed ID: 8245780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure.
    Lie WR; Myers NB; Connolly JM; Gorka J; Lee DR; Hansen TH
    J Exp Med; 1991 Feb; 173(2):449-59. PubMed ID: 1703208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.